Seagen Requests Director Review of Unpatentability Decision in Adcetris® Patent PGR | Venable LLP

On February 14, 2024, Seagen requested director review of the PTAB’s January 16th Final Written Decision (“FWD”) in PGR2021-00030 finding antibody-drug conjugate claims in U.S. Patent...

Related Keywords

April Breyer Menon ,Seagen Adcetris , ,Final Written Decision ,